Keep up to date with every new upload!

Join free & follow Clinical Trial Results Podcast
Share
  • 11 years ago
Christopher P. Cannon MD

Christopher P. Cannon MD

CTR satellite symposia presentation, Christopher P. Cannon MD discusses Results of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Study Program: Cardiovascular Outcomes Following Long-term Treatment with Etoricoxib vs Diclofenac in Patients with Osteoarthritis and Rheumatoid Arthritis.

Comments